A novel therapeutic approach for targeting TDP-43 in ALS
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210379
- Recipient
-
Gismo Therapeutics Inc. UEI SY29WJMD4E85
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,236,880
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Funding
-
- $618,440.00 Federal
- $618,440.00 Non-federal
- Place of performance
- Lexington, KY 40506, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Original award | $618,440 | $618,440 |
Quick answers
Who received award W81XWH2210379?
W81XWH2210379 was awarded to Gismo Therapeutics Inc. by Defense Health Agency (Department of Defense) on June 15, 2022.
How much is award W81XWH2210379 worth?
$1,236,880 has been obligated on W81XWH2210379: $618,440 in federal funding and $618,440 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award